![Joseph Reilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Reilly
Comptroller/Controller/Auditor at
ARDELYX, INC.
Net worth: 551 328 $ as of 31/08/2026
Profile
Joseph Reilly is Chief Accounting Officer at Ardelyx, Inc. since 2024.
Mr. Reilly was Vice President-Global Markets Controller at Bristol Myers Squibb Co. in 2024.
Mr. Reilly completed undergraduate studies at Syracuse University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC. 0.06% | 21/08/2026 | 145,854 ( 0.06% ) | 551 328 $ | 31/08/2026 |
Joseph Reilly active positions
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Comptroller/Controller/Auditor | 15/11/2024 |
Former positions of Joseph Reilly
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/09/2024 |
Training of Joseph Reilly
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Joseph Reilly
